UPCOMING WEBINAR
From Hit to IND: Streamlining Drug Discovery Through Multidisciplinary Integration
Drug discovery is inherently a time-consuming and costly endeavor. How can today's new drug innovators accelerate their programs through a simple, fast, and streamlined process—especially when working with multiple vendors? Should they rely on a single partner for end-to-end support, or engage specialized vendors for different workstreams such as chemistry, biology, and DMPK?